Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page's revision label updated from v3.5.4 to v3.5.5, indicating a minor version update to the page's documentation rather than a substantive change to the study content. This update does not modify any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-05T21:41:09.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.5.3 to v3.5.4. This reflects a minor site revision without altering the displayed content.
    Difference
    0.1%
    Check dated 2026-05-15T14:45:53.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A Publications subsection was added to the Study Record, listing the article 'Immunotherapy in B-Cell Acute Lymphoblastic Leukemia' by Davis KL et al. with DOI 10.6004/jnccn.2025.7067, and noting that publications are automatically filled from PubMed.
    Difference
    0.3%
    Check dated 2026-05-08T11:44:06.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a site/application version change without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:27:55.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:48:44.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Acute lymphoid leukemia is added, and the Genetic and Rare Diseases Information Center is listed under resources.
    Difference
    0.2%
    Check dated 2026-04-02T15:39:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.